Efficacy and Safety of DA-8010, a Novel M3 Antagonist, in Patients With Overactive Bladder: A Randomized, Double-Blind Phase 2 Study
Hee Seo Son, Cheol Young Oh, Myung-Soo Choo, Hyeong Gon Kim, Joon Chul Kim, Kyu-Sung Lee, Dong Gil Shin, Sung Yong Cho, Seong Jin Jeong, Ju Tae Seo, Hana Yoon, Hong Sang Moon, Jang Hwan Kim
Int Neurourol J. 2022;26(2):119-128.   Published online 2022 Jun 30
DOI: https://doi.org/10.5213/inj.2142382.191
Citations to this article as recorded by
  Crossref logo
Muscarinic control of cardiovascular function in humans: a review of current clinical evidence
Jose-Alberto Palma
Clinical Autonomic Research.2024; 34(1): 31.     CrossRef
Novel pharmacotherapeutic avenues for bladder storage dysfunction in men
Kang Jun Cho, Joon Chul Kim
Expert Opinion on Pharmacotherapy.2024; 25(5): 585.     CrossRef
Emerging therapies for overactive bladder: preclinical, phase I and phase II studies
Samantha Gibson, Pamela Ellsworth
Expert Opinion on Investigational Drugs.2024; 33(6): 601.     CrossRef
Evaluation of Food Effect on the Pharmacokinetics of Velufenacin, a New Muscarinic Receptor Antagonist, in Healthy Subjects
Juyoung Khwarg, Woo Kyung Chung, Soyoung Lee, Eunsol Yang, Chaelim Ryu, Dae Young Lee, Min Jung Lee, In‐Jin Jang, Kyung‐Sang Yu, SeungHwan Lee
Clinical Pharmacology in Drug Development.2023;[Epub]     CrossRef
Novel botulinum neurotoxin-A tibial nerve perineural injection to alleviate overactive bladder symptoms in male rats
Seungbeom Kim, Hyun Seok Na, Jong Mok Park, Jin Wook Kim
Animal Cells and Systems.2022; 26(6): 283.     CrossRef